HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo Genova Selected Research

Pemetrexed (MTA)

12/2018The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer.
10/2014Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview.
8/2013Pemetrexed for the treatment of non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlo Genova Research Topics

Disease

62Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 06/2012
39Neoplasms (Cancer)
08/2022 - 07/2012
18Lung Neoplasms (Lung Cancer)
03/2022 - 07/2012
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2022 - 07/2014
6Disease Progression
03/2021 - 06/2012
5Neoplasm Metastasis (Metastasis)
01/2022 - 10/2016
5Circulating Neoplastic Cells
12/2019 - 01/2014
4COVID-19
08/2022 - 01/2020
4Breast Neoplasms (Breast Cancer)
01/2021 - 01/2015
3Malignant Mesothelioma
04/2022 - 01/2016
3Adenocarcinoma of Lung
10/2016 - 06/2015
2Inflammation (Inflammations)
01/2022 - 06/2021
2Melanoma (Melanoma, Malignant)
01/2019 - 07/2012
2Carcinoma (Carcinomatosis)
01/2019 - 01/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2016 - 01/2016
1Infections
08/2022
1Asymptomatic Infections
08/2022
1Gastritis
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Sarcoma (Soft Tissue Sarcoma)
03/2021
1Persistent Infection
01/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Hodgkin Disease (Hodgkin's Disease)
01/2021
1Second Primary Neoplasms (Neoplasms, Second)
01/2021
1Obesity
10/2020
1Overweight
10/2020
1Thyroid Diseases (Thyroid Disease)
01/2020
1Hypertension (High Blood Pressure)
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020

Drug/Important Bio-Agent (IBA)

20Immune Checkpoint InhibitorsIBA
03/2022 - 01/2018
13Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
12NivolumabIBA
06/2021 - 01/2018
6Tyrosine Kinase InhibitorsIBA
05/2021 - 08/2014
6pembrolizumabIBA
01/2021 - 10/2020
5Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2016
5Monoclonal AntibodiesIBA
01/2021 - 07/2012
4PlatinumIBA
03/2022 - 01/2018
4Biological ProductsIBA
01/2022 - 10/2014
4LigandsIBA
01/2022 - 01/2019
4ErbB Receptors (EGF Receptor)IBA
05/2021 - 09/2015
4B7-H1 AntigenIBA
01/2021 - 01/2019
4MicroRNAs (MicroRNA)IBA
12/2019 - 01/2016
4Cell-Free Nucleic AcidsIBA
07/2019 - 12/2015
4DNA (Deoxyribonucleic Acid)IBA
03/2019 - 12/2015
4Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2018 - 06/2012
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 11/2017
3Pharmaceutical PreparationsIBA
01/2021 - 08/2013
3Pemetrexed (MTA)FDA Link
12/2018 - 08/2013
3AfatinibIBA
12/2018 - 04/2014
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2018 - 01/2016
2Anaplastic Lymphoma KinaseIBA
01/2022 - 03/2021
2osimertinibIBA
05/2021 - 01/2019
2CTLA-4 AntigenIBA
01/2021 - 07/2012
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2016
2Messenger RNA (mRNA)IBA
01/2019 - 01/2018
2AntibodiesIBA
01/2019 - 01/2018
2Circulating Tumor DNAIBA
01/2019 - 11/2017
2VaccinesIBA
01/2018 - 07/2012
2Oxygen (Dioxygen)IBA
01/2018 - 08/2013
2necitumumabIBA
01/2018 - 01/2016
2SolutionsIBA
01/2017 - 01/2016
2Formaldehyde (Formol)FDA Link
01/2016 - 12/2015
2ParaffinIBA
01/2016 - 12/2015
2Gefitinib (Iressa)FDA Link
06/2015 - 06/2012
2IpilimumabIBA
07/2014 - 07/2012
1Carboplatin (JM8)FDA LinkGeneric
03/2022
1Bevacizumab (Avastin)FDA Link
03/2022
1atezolizumabIBA
03/2022
1Etoposide (VP 16)FDA LinkGeneric
03/2022
1brigatinibIBA
01/2022
1C-Reactive ProteinIBA
01/2022
1ProcalcitoninIBA
01/2022
1human ERBB2 proteinIBA
03/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1Brentuximab VedotinIBA
01/2021
1Ado-Trastuzumab EmtansineIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1AntigensIBA
01/2021
1Cytotoxins (Cytolysins)IBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1Long-Acting Thyroid Stimulator (LATS)IBA
01/2021
1Estrogen ReceptorsIBA
01/2021
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2021
1SteroidsIBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1Proton Pump InhibitorsIBA
01/2021
1Cytostatic AgentsIBA
01/2021
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
04/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2020
1ORALIT (ORS)IBA
01/2020

Therapy/Procedure

23Therapeutics
08/2022 - 06/2012
17Immunotherapy
04/2022 - 01/2014
11Drug Therapy (Chemotherapy)
03/2022 - 08/2014
3Precision Medicine
01/2022 - 01/2015
2Lasers (Laser)
01/2018 - 01/2017
1Radiotherapy
01/2021
1Critical Care (Surgical Intensive Care)
01/2020
1Continuity of Patient Care
01/2020